Tamlin Vanessa S, Dobson Elizabeth C, Woolford Lucy, Peaston Anne E
School of Animal and Veterinary Sciences, University of Adelaide, Roseworthy, South Australia (Tamlin, Woolford, Peaston).
Gribbles Veterinary Pathology, Clayton, Victoria, Australia (Dobson).
J Vet Diagn Invest. 2019 Sep;31(5):756-760. doi: 10.1177/1040638719867743. Epub 2019 Aug 4.
DNA amplification by PCR detects exon 11 internal tandem duplications in canine mast cell tumors (MCTs). Tissue-specific inhibitors often contaminate DNA extracted from formalin-fixed, paraffin-embedded (FFPE) canine MCTs, blocking PCR amplification and, consequently, preventing mutation detection. We used a commercial kit to extract DNA from FFPE canine MCTs. Two independent PCR assays, each with one primer set, were used to amplify target genes ( and ) directly after FFPE DNA extraction. PCR amplification failed with at least one primer set in 153 of 280 samples (54.6%, 95% CI: 48.8-60.5%). One or 2 DNA washing steps were required to remove PCR inhibitors in 130 of 280 (46.4%) and 23 of 280 (8.2%) of these cases, respectively. DNA concentration and quality (A/A and A/A) either pre- or post-washing were not associated with ability of the samples to be amplified by PCR using both and primer sets. Low-grade and subcutaneous MCTs were less likely to amplify directly after DNA extraction and without any washing steps compared to high-grade MCTs using gene primers.
通过聚合酶链反应(PCR)进行DNA扩增可检测犬肥大细胞瘤(MCT)中外显子11内部串联重复。组织特异性抑制剂常常污染从福尔马林固定、石蜡包埋(FFPE)的犬MCT中提取的DNA,阻碍PCR扩增,从而无法检测到突变。我们使用一种商业试剂盒从FFPE犬MCT中提取DNA。在FFPE DNA提取后,使用两个独立的PCR检测,每个检测使用一组引物,直接扩增靶基因(和)。在280个样本中,至少一组引物的PCR扩增失败的有153个(54.6%,95%可信区间:48.8 - 60.5%)。在这些病例中,分别有130个(46.4%)和23个(8.2%)需要进行一步或两步DNA洗涤步骤以去除PCR抑制剂。洗涤前后的DNA浓度和质量(A/A和A/A)与样本使用和引物组通过PCR扩增的能力无关。与使用基因引物的高级别MCT相比,低级别和皮下MCT在DNA提取后且无任何洗涤步骤的情况下直接扩增的可能性较小。